Literature DB >> 27042282

Case of anal fistula with Fournier's gangrene in an obese type 2 diabetes mellitus patient.

Hiroshi Yoshino1, Kyoko Kawakami1, Gen Yoshino1, Katsuhiro Sawada2.   

Abstract

A 64-year-old man was admitted to Shin-suma General Hospital, Kobe, Japan, complaining of a 3-day history of scrotal swelling and high fever. He had type 2 diabetes mellitus. On examination, his body temperature had risen to 38.5 °C. Examination of the scrotum showed abnormal enlargement. Laboratory data were as follows: white cell count 35,400/μL and glycated hemoglobin 9.6%. Anal fistula was found in an endorectal ultrasound. Computed tomography scan showed a relatively high density of subcutaneous tissue and elevated air density. Thus, he was diagnosed with Fournier's gangrene. On the fourth hospital day, the patient underwent debridement of gangrenous tissue. Seton surgery was carried out for anal fistula on the 34th hospital day. He responded to the treatment very well. He was discharged on the 33rd postoperative day. Once Fournier's gangrene has been diagnosed, considering the association of anal fistula and perianal abscess is important.

Entities:  

Keywords:  Anal fistula; Diabetes mellitus; Fournier's gangrene

Mesh:

Year:  2015        PMID: 27042282      PMCID: PMC4773667          DOI: 10.1111/jdi.12355

Source DB:  PubMed          Journal:  J Diabetes Investig        ISSN: 2040-1116            Impact factor:   4.232


Introduction

Fournier's gangrene (FG) was first reported in 1883 by Jean Alfred Fournier1. FG is characterized by a polymicrobial infection (aerobic and anaerobic bacteria) with an identifiable cause in 95% of cases, beginning in the genital or perineal regions2. It has a high death rate and an acute surgical emergency is required. Here, we present the case of an anal fistula with FG in an obese type 2 diabetes mellitus patient.

Case Report

A 64‐year‐old Japanese man was admitted to Shin‐suma General Hospital, Kobe, Japan, complaining of a 3‐day history of scrotal swelling and high fever. He had type 2 diabetes mellitus with an 18‐year history of irregular treatment. Three days before admission, he visited a neighborhood general physician because of painful scrotum. He was given a diagnosis of perianal abscess. Incisional drainage was carried out. However, the symptoms worsened. On examination, his height, bodyweight, and body mass index were 186.0 cm, 113.0 kg and 32.1 kg/m2, respectively, and his body temperature rose to 38.5°C. Examination of the scrotum found abnormal enlargement. Laboratory data were as follows: white cell count 35,400/μL with increased polymorph nuclear leukocytosis (90%), hemoglobin 15.3 g/dL, C‐reactive protein 31.3 mg/dL, blood urea nitrogen 21.7 mg/dL, serum creatinine 1.0 mg/dL, glycated hemoglobin 9.6% (National Glycohemoglobin Standardization Program) and blood glucose 389 mg/dL. Anal fistula was found by an endorectal ultrasound. Computed tomography scan showed relatively a high density of subcutaneous tissue and elevated air density (Figure 1). Thus, he was diagnosed with FG. Intravenous administration of ceftriaxone 1 g/day was started. However, the next day, that was replaced by meropenem 1 g/day with a broader spectrum.
Figure 1

Air was found in the left testis in enhanced computed tomography (shown by an arrow).

Air was found in the left testis in enhanced computed tomography (shown by an arrow). Simultaneously, an emergency incisional drainage was carried out. The pus was sent for microbial culture and sensitivity test. Culture showed infection of α‐Streptococcus. Blood sugar level was well controlled within 100–200 mg/dL by intravenous insulin therapy. On the fourth hospital day, the patient underwent debridement of gangrenous tissue. Seton surgery was carried out for anal fistula on the 34th hospital day. He responded to the treatment very well. Laboratory data and body temperature were improved (Figure 2). Blood glucose level was evaluated by continuous glucose monitoring (Figure 3). He was discharged on the 33rd postoperative day.
Figure 2

Clinical course. CTRX, ceftriaxone; MINO, minomycin; MPEM, meropenem; SBT/CPZ, sulbactam/cefoperazone.

Figure 3

The 24‐h glucose profile using a continuous glucose monitoring system (ipro2Ⓡ Medtronic). (a) Day 16 and (b) day 36.

Clinical course. CTRX, ceftriaxone; MINO, minomycin; MPEM, meropenem; SBT/CPZ, sulbactam/cefoperazone. The 24‐h glucose profile using a continuous glucose monitoring system (ipro2Ⓡ Medtronic). (a) Day 16 and (b) day 36.

Discussion

FG has a serious surgical problem, because it is commonly associated with a polymicrobial infection of genitourinary or perianal source with high mortality and morbidity. Computed tomography scan has a significant value for the evaluation of the extent of the disease3. It has been found that 55% of FG patients have diabetes mellitus4. Obesity cannot be a main predisposing factor5. Mean leukocyte count was higher in patients who died than in surviving patients6. One of the most important prognostic factors influencing mortality was found to be hemodialysis‐dependent chronic renal failure, with a death rate of 50%6. In the present patient, renal function was maintained. According to Hämäläinen, 37% of patients developed an anal fistula after incision and drainage of an anorectal abscess7. Fistulas typically develop after rupture or drainage of a perianal abscess8. In the present case, perianal abscess was found at a neighborhood general physician. However, we were unable to detect a relationship between perianal abscess and anal fistula. A total of 27% of patients with FG had perianal abscess, and 9% had anal fistula4. Thus, once FG has been diagnosed, considering the association of anal fistula with perianal abscess is important. We conclude that earlier detection and intervention can provide opportunities to improve outcomes of FG.

Disclosure

The authors declare no conflict of interest.
  8 in total

1.  Management of Fournier's gangrene: experience of a university hospital of Curitiba.

Authors:  Adriano Antonio Mehl; Dorivam Celso Nogueira Filho; Lucas Marques Mantovani; Michele Mamprim Grippa; Ralf Berger; Denise Krauss; Denise Ribas
Journal:  Rev Col Bras Cir       Date:  2010-12

Review 2.  Radiology of Fournier's gangrene.

Authors:  D K Rajan; K A Scharer
Journal:  AJR Am J Roentgenol       Date:  1998-01       Impact factor: 3.959

3.  Fournier's gangrene: etiology, treatment, and complications.

Authors:  A Kiliç; Y Aksoy; L Kiliç
Journal:  Ann Plast Surg       Date:  2001-11       Impact factor: 1.539

4.  Incidence of fistulas after drainage of acute anorectal abscesses.

Authors:  K P Hämäläinen; A P Sainio
Journal:  Dis Colon Rectum       Date:  1998-11       Impact factor: 4.585

Review 5.  Anorectal conditions: anal fissure and anorectal fistula.

Authors:  Audralan Fox; Pamela H Tietze; Kalyanakrishnan Ramakrishnan
Journal:  FP Essent       Date:  2014-04

6.  Fournier's gangrene: ten-year experience in a medical center in northern Taiwan.

Authors:  Chen-Feng Kuo; Wei-Sheng Wang; Chun-Ming Lee; Chang-Pan Liu; Hsiang-Kuang Tseng
Journal:  J Microbiol Immunol Infect       Date:  2007-12       Impact factor: 4.399

7.  Factors affecting mortality in Fournier's gangrene: experience with fifty-two patients.

Authors:  Feyzullah Ersoz; Serkan Sari; Soykan Arikan; Melih Altiok; Hasan Bektas; Gokhan Adas; Bekir Poyraz; Ozhan Ozcan
Journal:  Singapore Med J       Date:  2012-08       Impact factor: 3.331

8.  Case of anal fistula with Fournier's gangrene in an obese type 2 diabetes mellitus patient.

Authors:  Hiroshi Yoshino; Kyoko Kawakami; Gen Yoshino; Katsuhiro Sawada
Journal:  J Diabetes Investig       Date:  2015-07-31       Impact factor: 4.232

  8 in total
  4 in total

Review 1.  Fournier's Gangrene: Literature Review and Clinical Cases.

Authors:  Sergey A Chernyadyev; Marina A Ufimtseva; Irina F Vishnevskaya; Yuri M Bochkarev; Alexey A Ushakov; Tatiana A Beresneva; Farid V Galimzyanov; Valery V Khodakov
Journal:  Urol Int       Date:  2018-06-27       Impact factor: 2.089

2.  Pattern and outcome of management of Fournier's gangrene in a resource-constraint setting.

Authors:  Ngwobia Peter Agwu; Abubakar Sadiq Muhammad; Abdulwahab-Ahmed Abdullahi; Bello Bashir; Jacob Ndas Legbo; Ismaila Arzika Mungadi
Journal:  Urol Ann       Date:  2020-07-17

3.  Management of Fournier's gangrene during the Covid-19 pandemic era: make a virtue out of necessity.

Authors:  Alessio Paladini; Giovanni Cochetti; Angelica Tancredi; Matteo Mearini; Andrea Vitale; Francesca Pastore; Paolo Mangione; Ettore Mearini
Journal:  Basic Clin Androl       Date:  2022-07-19

4.  Case of anal fistula with Fournier's gangrene in an obese type 2 diabetes mellitus patient.

Authors:  Hiroshi Yoshino; Kyoko Kawakami; Gen Yoshino; Katsuhiro Sawada
Journal:  J Diabetes Investig       Date:  2015-07-31       Impact factor: 4.232

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.